Atlas Trials

A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness

Clinical trial NCT06803654 · COMPLETED

Trial details

NCT number
NCT06803654
Sponsor
Bausch & Lomb Incorporated
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ocular Redness
Start date
2025-05-22
Primary completion
2025-06-29
Enrollment
578

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.